756873-20-8

Upstream product

• 1039387-76-2 2-bromo-1,3-dimethyl-5-phenoxybenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 925441-35-6 4-fluoro-2,6-dimethylbenzaldehyde 
• 108-95-2 phenol 

Downstream Products

• 756873-21-9 (2,6-dimethyl-4-phenoxyphenyl)-methanol 

Relevant academic research and scientific papers

NOVEL BRADYKININ B1-ANTAGONISTS

The present invention relates to compounds of general formula I wherein n, R1, R2, R3, R4, R5, R6, R7 and R8 are defined as stated hereinafter, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.

NITROGENOUS HETEROCYCLIC DERIVATIVE HAVING 2,6-DISUBSTITUTED STYRYL

The invention provides a novel nitrogen-containing heterocyclic derivative having 2,6-disubstituted styryl and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the nitrogen-containing heterocyclic derivative and a pharmaceutically acceptable salt thereof, in particular, a pharmaceutical composition effective as a sodium channel inhibitor, having an excellent analgesic action especially on neuropathic pain with minimized side effects.